Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021

BACKGROUND: Chimeric antigen receptor (CAR)-based immunotherapy has shown great potential for the treatment of both hematopoietic malignancies and solid tumors. Nevertheless, multiple obstacles still block the development of CAR-based immunotherapy in the clinical setting. In this study, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Zhanpeng, Qiu, Ling, Rong, Haixu, Li, Bowen, Ren, Siqi, Kuang, Shijia, Lan, Tianjun, Lin, Hsinyu, Li, Qunxing, Wu, Fan, Cai, Tingting, Yan, Lingjian, Ye, Yushan, Fan, Song, Li, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005877/
https://www.ncbi.nlm.nih.gov/pubmed/35432345
http://dx.doi.org/10.3389/fimmu.2022.822004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005877/
https://www.ncbi.nlm.nih.gov/pubmed/35432345
http://dx.doi.org/10.3389/fimmu.2022.822004

Ejemplares similares